000 01477 a2200421 4500
005 20250513175216.0
264 0 _c19990429
008 199904s 0 0 eng d
022 _a0304-3835
024 7 _a10.1016/s0304-3835(98)00388-7
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aGagandeep, S
245 0 0 _aPaclitaxel shows cytotoxic activity in human hepatocellular carcinoma cell lines.
_h[electronic resource]
260 _bCancer letters
_cFeb 1999
300 _a109-18 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.
650 0 4 _aAdolescent
650 0 4 _aAntineoplastic Agents, Phytogenic
_xpharmacology
650 0 4 _aApoptosis
_xdrug effects
650 0 4 _aCarcinoma, Hepatocellular
_xdrug therapy
650 0 4 _aCell Cycle
_xdrug effects
650 0 4 _aDrug Synergism
650 0 4 _aFlow Cytometry
650 0 4 _aHumans
650 0 4 _aImmunohistochemistry
650 0 4 _aKidney Tubules
_xdrug effects
650 0 4 _aLiver Neoplasms
_xdrug therapy
650 0 4 _aMale
650 0 4 _aPaclitaxel
_xpharmacology
650 0 4 _aThymidine
_xmetabolism
650 0 4 _aTumor Cells, Cultured
650 0 4 _aVerapamil
_xpharmacology
700 1 _aNovikoff, P M
700 1 _aOtt, M
700 1 _aGupta, S
773 0 _tCancer letters
_gvol. 136
_gno. 1
_gp. 109-18
856 4 0 _uhttps://doi.org/10.1016/s0304-3835(98)00388-7
_zAvailable from publisher's website
999 _c10171186
_d10171186